Contract Development and Manufacturing Organizations (CDMOs) play an essential role in bringing innovative therapies to market. Yet for many mid-market CDMOs, scientific and technical capabilities have advanced faster than the commercial organizations responsible for translating those capabilities into sustainable growth.
A company may possess outstanding technical expertise, strong regulatory credentials, and sophisticated manufacturing infrastructure while still struggling to build a predictable sales pipeline, differentiate its services, or consistently convert opportunities into profitable contracts.
For executive leadership teams and private equity investors, addressing these challenges is fundamental to building enterprise value.
Five commercial priorities deserve particular attention.
1. Differentiation in an Increasingly Competitive Market
Many CDMOs describe their value proposition using similar language: technical excellence, quality, flexibility, customer focus, and regulatory compliance.
These attributes are important, but they rarely provide sufficient differentiation on their own.
Customers increasingly want to understand how a CDMO will reduce development risk, accelerate timelines, improve technology transfer, or provide greater certainty around complex manufacturing programs.
The challenge: Translating technical capabilities into a compelling commercial value proposition that resonates with specific customer segments.
The opportunity: Build differentiation around the problems the organization is uniquely positioned to solve.
This requires answering three questions:
- Which customer segments and therapeutic modalities represent the strongest strategic fit?
- Where does the organization possess demonstrable advantages over competitors?
- How do those advantages translate into measurable customer value?
A focused market positioning strategy should influence not only marketing communications but also account targeting, opportunity qualification, pricing, and investment decisions.
Executive takeaway: Sustainable differentiation comes from demonstrating superior customer outcomes, not simply listing technical capabilities.
2. Building a Predictable Commercial Pipeline
CDMO sales cycles are often lengthy, technically complex, and influenced by factors outside the service provider's control.
Customer funding, clinical development milestones, regulatory decisions, and manufacturing readiness can all affect the timing and probability of a contract award.
These characteristics make disciplined pipeline management particularly important.
However, many organizations still rely heavily on individual sales judgment, inconsistent opportunity qualification, and optimistic revenue forecasts.
The challenge: Creating sufficient visibility into future demand while improving the reliability of commercial forecasts.
The opportunity: Establish a consistent, data-driven commercial operating model.
Key elements include:
- Clearly defined opportunity qualification criteria.
- Consistent sales stages linked to observable customer commitments.
- Probability assessments based on evidence rather than optimism.
- Regular pipeline reviews focused on advancing opportunities and removing obstacles.
- Better integration of commercial forecasts with capacity and resource planning.
Pipeline quality should matter as much as pipeline size.
A smaller portfolio of well-qualified opportunities can be more valuable than an inflated pipeline containing projects with limited probability of conversion.
Executive takeaway: Predictable growth begins with disciplined opportunity management and realistic forecasting.
3. Aligning Sales, Marketing, and Technical Operations
CDMO business development is fundamentally a cross-functional activity.
Successful customer acquisition frequently requires contributions from business development, technical subject matter experts, process development, manufacturing, quality, regulatory affairs, finance, and executive leadership.
Yet these groups may operate with different priorities, incentives, and expectations.
Sales teams may pursue opportunities that do not align with operational capabilities. Technical teams may become involved too late in the sales process. Marketing may generate leads without sufficient consideration of commercial fit.
The result can be slower proposals, inconsistent customer experiences, and wasted organizational resources.
The challenge: Ensuring the entire organization works toward a common set of commercial priorities.
The opportunity: Establish clear governance for customer acquisition and opportunity execution.
Practical improvements include:
- Defining target customer profiles and preferred project characteristics.
- Introducing cross-functional qualification and bid/no-bid decisions.
- Clarifying accountability for proposals, technical assessments, and pricing.
- Establishing common performance metrics across commercial and operational teams.
- Creating structured handoffs from contract award to project execution.
The objective is not to add bureaucracy. It is to improve decision-making, reduce friction, and allocate scarce technical resources to the most attractive opportunities.
Executive takeaway: Commercial effectiveness is an organizational capability, not simply a sales department responsibility.
4. Improving Pricing Discipline and Profitability
Revenue growth does not automatically translate into value creation.
CDMOs operate with complex cost structures, specialized infrastructure, significant technical labor requirements, and varying degrees of capacity utilization.
Pricing decisions must account for project complexity, technical risk, resource requirements, competitive alternatives, and the strategic value of customer relationships.
In practice, pricing is sometimes driven more by competitive pressure or near-term revenue objectives than by a structured assessment of profitability.
The challenge: Balancing commercial competitiveness with sustainable economic returns.
The opportunity: Introduce greater discipline into pricing, deal evaluation, and contract governance.
Management teams should consider:
- Consistent project-level costing and contribution-margin analysis.
- Pricing frameworks that reflect complexity, urgency, and technical risk.
- Clear approval thresholds for discounts and commercial exceptions.
- Contract structures that address scope changes and resource commitments.
- Post-project reviews comparing estimated and realized profitability.
These practices also help identify situations where the organization is winning work that does not adequately compensate it for the resources or risks involved.
Executive takeaway: Profitable growth requires understanding not only which business can be won, but which business should be won.
5. Building a Commercial Organization That Can Scale
Many mid-market CDMOs initially grow through founder relationships, technical reputation, or the efforts of a small number of highly experienced business development professionals.
This model can be effective during early growth but becomes increasingly difficult to scale.
As the organization expands into new services, geographies, and customer segments, commercial complexity increases.
Without appropriate structure, businesses can become overly dependent on individual relationships, experience inconsistent sales execution, or struggle to integrate newly acquired capabilities.
The challenge: Moving from relationship-dependent growth to a repeatable commercial operating model.
The opportunity: Design the organization around future growth requirements rather than historical structures.
Important considerations include:
- Clearly defined roles and responsibilities across business development, account management, and marketing.
- Appropriate segmentation of customers and territories.
- Sales incentive plans aligned with profitable growth and strategic priorities.
- Leadership capabilities suited to the organization's next stage of development.
- Commercial performance dashboards that support timely management decisions.
- Scalable processes that can accommodate acquisitions or expansion into adjacent services.
For private equity-backed organizations, these capabilities are especially important because they support integration, execution consistency, and a more credible growth story.
Executive takeaway: Scalable commercial organizations are intentionally designed, not simply expanded through additional headcount.
From Commercial Challenges to Competitive Advantage
These five challenges are closely connected.
Weak differentiation makes pipeline development more difficult. Poor qualification consumes technical resources. Organizational misalignment slows conversion. Inconsistent pricing undermines profitability. And inadequate commercial infrastructure limits the ability to scale.
Addressing each issue independently may deliver incremental improvements. Addressing them as an integrated commercial transformation can create more sustainable competitive advantage.
For CDMO leadership teams, a useful starting point is a structured assessment of five questions:
- Are we clearly differentiated in the markets where we compete?
- Can we reliably forecast and convert our commercial pipeline?
- Are our commercial and technical organizations aligned around the right opportunities?
- Do our pricing and contracting practices support profitable growth?
- Is our commercial operating model capable of supporting our next phase of expansion?
The answers can provide a practical foundation for prioritizing investments, improving execution, and accelerating growth.
Ultimately, the objective is not simply to generate more opportunities. It is to build a commercial organization capable of consistently identifying, winning, and executing the right business.
About Alator Business Solutions
Alator Business Solutions provides strategic and commercial advisory services to organizations across the life sciences services industry, including CDMOs, CROs, and analytical testing providers.
Founded by Jarlath F. Keating, Alator supports leadership teams and investors through strategy development, sales force effectiveness, marketing strategy, organizational design, commercial operations optimization, and fractional executive leadership.
Strengthening Business. Enabling Growth.
